SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001607062-14-000210
Filing Date
2014-12-22
Accepted
2014-12-22 08:20:11
Documents
5
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A rgbp20149030form10ka.htm 10-K/A 262971
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER rgbp20149030form10kaex31_1.htm EX-31.1 7958
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER rgbp20149030form10kaex31_2.htm EX-31.2 7862
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER rgbp20149030form10kaex32_1.htm EX-32.1 4199
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER rgbp20149030form10kaex32_2.htm EX-32.2 3838
  Complete submission text file 0001607062-14-000210.txt   287801
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-191725 | Film No.: 141301628
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1